Chronic Coronary Disease Guideline E2: Risk Assessment and Lifestyle Factors
You are currently not logged in to PHD
To view this content, please login to your account, or within the login, click 'Create an Account' for guest access.
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Risk assessment is the foundation that treatment decisions are built upon. In this episode, Dr. Virani and Newby discuss the guideline's detailed recommendations when it comes to evaluation and risk assessment, including the encouragement to defer testing in certain patients due to its inherent risks and costs. They also go into the lifestyle factors that play an important role in managing CCD, including optimal nutrition and exercise. And they emphasize the guideline's recommendations on how to best counsel patients about drug and alcohol use.
Recommended Videos
2024 PAD Guideline: Call to Action
What's New in the 2024 PAD Guideline?
Approach to Chronic Symptomatic PAD from the 2024 PAD Guideline
What is Life's Essential 8™?
Key Updates from previous Guideline for Perioperative Cardiovascular Manag...
Loading...
Save Video
Please note: American Heart Association does not associate with, nor endorse YouTube recommendations.
Video is not available. Please check the URL.